In Vitro & In Vivo Diagnostic Substances · DE · CIK 1850902
Produces critical reagents for therapy, vaccine, and diagnostic development
Comparable business profile · signals at a glance
In the 90 days to Mar 6, 2026: 2 insiders bought $144K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 6, 2026 | Lowell MatthewChief Financial Officer | Buy | 40,000 | $2.19 | $88K |
| Mar 6, 2026 | Gunstream StephenPresident and CEO | Buy | 26,000 | $2.15 | $56K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.